GLP-1 receptor agonists — the class of drugs behind Ozempic, Wegovy and Mounjaro — have reshaped millions of patients' bodies. Now they are reshaping dental consultations.
As patients lose significant weight in compressed timeframes, clinicians are seeing changes to facial volume, lip support and smile dynamics that complicate everything from denture fit to cosmetic treatment timing.
Dr. Whitney White, a dentist and practice owner at Aspen Dental in Las Vegas who specializes in restorative, surgical, and prosthetic dentistry, recently shared her clinical perspective on what GLP-1 patients are bringing to the chair, how she is adjusting her treatment planning, and why the most important conversation a dentist can have with these patients often has nothing to do with a shade guide.
DrBicuspid: What specific esthetic changes are you observing in patients who have lost significant weight on GLP-1 drugs — facial volume, lip support, smile line, tooth-to-lip relationship?
Dr. Whitney WhiteDr. Whitney White
Are any of those changes creating complications or surprises in treatment planning that you weren't anticipating early on?
One of the biggest considerations is timing. If a patient is still actively losing weight, their facial structure may continue to change, which can affect the final esthetic outcome. A smile design that looks balanced at one point in the process may need to be adjusted if the patient’s facial volume, lip support, or smile line changes later. That’s why it’s important for dentists to understand the patient’s full health history, including any medications they’re taking and whether their weight is still changing.
At what point in a patient's weight-loss journey do facial changes tend to stabilize enough that you feel comfortable moving forward with irreversible restorative work?
This really depends on the patient, but I would generally want to see that their weight and overall health have stabilized before moving forward with irreversible restorative work. If someone is still actively losing weight, it may be worth taking a more conservative approach or waiting until their facial changes have leveled out. The goal is always to create a result that looks natural not just today, but in the long term.
How has GLP-1-related dry mouth factored into your clinical decision-making — are you seeing elevated caries risk, soft tissue changes, or complications with certain materials or adhesives?
Medications like GLP-1s may contribute to dry mouth for some patients, which is an important oral health consideration. Saliva plays a critical role in protecting teeth by helping wash away food particles and bacteria, so when saliva flow is reduced, bacteria can remain on the teeth longer, especially near the gumline, potentially increasing the risk for cavities and sensitivity. Clinically, this can translate to a higher caries risk and early soft tissue irritation in some patients. For those reporting dry mouth, I recommend being proactive with prevention through regular checkups, strong at-home care, and incorporating xylitol-containing products, particularly for patients who are more cavity-prone, to help support saliva production and reduce bacterial load.
Have you seen cases where the smile design a patient wanted at the start of treatment needed to be revised midway through because their face continued to change? How did you handle that?
I have not personally seen this as a major trend yet, but it is something dental professionals should be mindful of. If a patient’s face continues to change, it’s important to set expectations early that their treatment plan may need to evolve. That can mean taking updated photos, reassessing the smile in relation to the lips and face, and having an honest conversation about whether to move forward or wait until changes have stabilized.
Treatment planning and sequencing
How has your treatment planning process changed — or should change — for patients who are actively losing weight versus those who have plateaued?
The biggest difference comes down to timing and flexibility. For patients who are actively losing weight, I would take a more conservative and phased approach to treatment planning, focusing first on maintaining oral health and addressing any immediate concerns. If a patient’s facial structure is still changing, it can impact how their smile ultimately looks, so it’s important to build in room for adjustments. For patients who have plateaued and whose weight has stabilized, it becomes much easier to move forward with more definitive or cosmetic treatments. At that point, we have a clearer understanding of their facial proportions and can design a smile that feels balanced and long-lasting.
Are there restorative options you are steering these patients toward or away from specifically because of GLP-1-related considerations?
It’s less about steering patients toward or away from specific procedures and more about making sure the timing and foundation are right. If a patient is experiencing side effects like dry mouth, I would want to address that first since it can increase the risk of decay or sensitivity.
I would be more cautious with irreversible treatments, things like starting a permanent denture or cosmetic veneers. I’d focus on preventative care, monitoring, and potentially more temporary or reversible options until we know their oral health and facial structure are stable.
What role does photography and digital smile design play in managing expectations with this patient population — and are those tools sufficient, or do they fall short?
Photography and digital smile design are incredibly helpful tools for setting expectations and helping patients visualize potential outcomes. They allow us to map out how a smile might look in relation to a patient’s current facial features, which is especially valuable in cosmetic planning.
That said, these tools are based on a moment in time. If a patient’s face continues to change due to weight loss, those projections may shift as well. I always make it clear that while these tools are a great guide, they’re not static predictions. Ongoing communication and reassessment are key to making sure the final result aligns with the patient’s goals.
The patient conversation
How do you explain the timing risk to a patient who is excited about their transformation and ready to move forward immediately?
I always start by acknowledging how exciting that transformation can be. Many patients feel more confident and ready to invest in their smiles, which is a great thing. From there, I explain that if their body and in turn their facial structure is still changing, it can impact how their final smile looks over time. I frame it less as a limitation and more as a way to protect their investment. The goal is to make sure the result looks natural and lasts long term, not just in the moment. In some cases, that may mean taking a phased approach or waiting until things have stabilized before moving forward with more permanent treatments.
Have you had patients push back on a "wait and see" recommendation? How do you navigate that conversation without losing them?
It’s not uncommon for patients to feel eager to move forward, especially if they’re feeling good about the progress they’ve made. When that happens, I focus on education and transparency. I walk them through what could change if we move too quickly and how that might impact their results down the line. At the same time, I try to meet them where they are. That might mean identifying smaller, lower-risk steps we can take in the meantime or setting a clear timeline for when we can revisit more comprehensive treatment. Keeping the conversation collaborative helps patients feel heard while still prioritizing what’s best for their long-term outcome.
Is there a consent or documentation piece specific to GLP-1 patients that you have added to your process?
There isn’t necessarily a GLP-1-specific consent, but it does reinforce how important it is to have a complete and up-to-date medical history. I always encourage patients to be open about any medications they’re taking so we can factor that into their care. For patients who are actively losing weight or experiencing side effects like dry mouth, I would make sure those considerations are documented as part of the treatment planning process. That includes noting any potential timing considerations, setting clear expectations, and ensuring the patient understands how changes in their health or weight could impact their results.
